Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 50Recruiting 14Terminated 13Unknown 8Withdrawn 5Active not recruiting 4Not yet recruiting 3

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 2CNS 2Sarcoma 1

Conditions

Keratosis, Actinic 2Glioma 2Glioblastoma 2Brain Neoplasms 2Sarcoma 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Aminolevulinic Acid × Clear all
NCT06252727 2024-08-15

Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)

University of California, Davis

Phase 1 Withdrawn
Sarcoma

Sarcoma

NCT02867722 2021-02-01

DaylightPDT

Brigham and Women's Hospital

Phase NA Withdrawn
Dermatologic

Keratosis, Actinic

NCT00977795 2019-09-10

A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors

Endeavor Health

Phase 1/2 Withdrawn
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT03024060 2017-11-07

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

DUSA Pharmaceuticals, Inc.

Phase 3 Withdrawn
Dermatologic

Keratosis, Actinic

NCT01445691 2016-05-17

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Icahn School of Medicine at Mount Sinai

Phase 2 Withdrawn
CNS

Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡